News Digest / Ticker: CTXR

Ticker: CTXR

05:24pm, Tuesday, Aug 12, 2025
Company: Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) What's happening inside the company - Citius is transitioning from development to commercial stage - FDA-approved LYMPHIR (denileukin diftitox) (approval Aug 8, 2024) and preparing a U.S. commercial launch targeted for Q4 2025. - The majority-o...